Literature DB >> 24859912

Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes.

Ernesto Maddaloni1, Luca D'Onofrio, Angelo Lauria, Anna Rita Maurizi, Rocky Strollo, Andrea Palermo, Nicola Napoli, Silvia Angeletti, Paolo Pozzilli, Silvia Manfrini.   

Abstract

PURPOSE: Diabetic osteopathy is an upcoming complication of diabetes characterized by osteoporosis, increased risk for bone fractures and alterations in bone metabolism. Osteocalcin (OC) is a bone-specific protein produced by osteoblasts involved in the regulation of glucose and energy metabolism. The aim of this study is to determine whether OC serum levels are correlated with metabolic control in adult subjects with type one diabetes mellitus (T1DM).
METHODS: A cross-sectional study was conducted on 93 subjects (51 men) with mean age, disease duration and body mass index (BMI) of 39.9 ± 12.3, 17.2 ± 12.6 years and 24.5 ± 3.4 kg/m(2), respectively. Blood samples were drawn to measure levels of hemoglobin A1c (HbA1c), OC, 25-OH vitamin D and PTH.
RESULTS: Significant inverse correlations were found between OC and HbA1c (r = -0.295, P = 0.004) and between OC and BMI (r = -0.218, P = 0.037). These correlations were confirmed also among men in the analyses by gender [HbA1c vs OC: r = -0.363, P = 0.009; BMI vs OC: r = -0.291, P = 0.043], and similar but nonsignificant trends were confirmed among women. A significant difference in mean OC was also found between the lowest and the highest HbA1c tertile (22.3 ± 10.0 vs 16.9 ± 8.0 ng/mL, P = 0.025).
CONCLUSIONS: These data show that in T1DM of long duration, OC serum levels are inversely associated with HbA1c and BMI, supporting the hypothesis that a poor glycemic control can affect osteoblast function.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24859912     DOI: 10.1007/s40618-014-0092-7

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  41 in total

1.  Serum osteocalcin is inversely associated with adipocyte-specific fatty acid-binding protein in the Korean metabolic syndrome research initiatives.

Authors:  Yun Jung Lee; Heeyeon Lee; Sun Ha Jee; Seong Su Lee; Sung Rae Kim; Seon Mee Kim; Myung Won Lee; Chang Beom Lee; Seungjoon Oh
Journal:  Diabetes Care       Date:  2010-07       Impact factor: 19.112

Review 2.  Clinical review: The role of advanced glycation end products in progression and complications of diabetes.

Authors:  Su-Yen Goh; Mark E Cooper
Journal:  J Clin Endocrinol Metab       Date:  2008-01-08       Impact factor: 5.958

3.  Biochemical markers of bone cell activity in children with type 1 diabetes mellitus.

Authors:  Agnieszka Pater; Grazyna Sypniewska; Olgierd Pilecki
Journal:  J Pediatr Endocrinol Metab       Date:  2010 Jan-Feb       Impact factor: 1.634

4.  An ELISA-based method to quantify osteocalcin carboxylation in mice.

Authors:  Mathieu Ferron; Jianwen Wei; Tatsuya Yoshizawa; Patricia Ducy; Gerard Karsenty
Journal:  Biochem Biophys Res Commun       Date:  2010-06-04       Impact factor: 3.575

5.  Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus.

Authors:  P Gerdhem; A Isaksson; K Akesson; Karl J Obrant
Journal:  Osteoporos Int       Date:  2005-04-12       Impact factor: 4.507

Review 6.  Understanding the pathology and mechanisms of type I diabetic bone loss.

Authors:  Laura R McCabe
Journal:  J Cell Biochem       Date:  2007-12-15       Impact factor: 4.429

7.  Endocrine regulation of energy metabolism by the skeleton.

Authors:  Na Kyung Lee; Hideaki Sowa; Eiichi Hinoi; Mathieu Ferron; Jong Deok Ahn; Cyrille Confavreux; Romain Dacquin; Patrick J Mee; Marc D McKee; Dae Young Jung; Zhiyou Zhang; Jason K Kim; Franck Mauvais-Jarvis; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2007-08-10       Impact factor: 41.582

8.  Relationship between osteocalcin and glucose metabolism in postmenopausal women.

Authors:  Jee-Aee Im; Byung-Pal Yu; Justin Y Jeon; Sang-Hwan Kim
Journal:  Clin Chim Acta       Date:  2008-07-04       Impact factor: 3.786

9.  Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men.

Authors:  Jenny M Kindblom; Claes Ohlsson; Osten Ljunggren; Magnus K Karlsson; Asa Tivesten; Ulf Smith; Dan Mellström
Journal:  J Bone Miner Res       Date:  2009-05       Impact factor: 6.741

10.  Bone recognition mechanism of porcine osteocalcin from crystal structure.

Authors:  Quyen Q Hoang; Frank Sicheri; Andrew J Howard; Daniel S C Yang
Journal:  Nature       Date:  2003-10-30       Impact factor: 49.962

View more
  16 in total

Review 1.  Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts.

Authors:  Evangelia Kalaitzoglou; Iuliana Popescu; R Clay Bunn; John L Fowlkes; Kathryn M Thrailkill
Journal:  Curr Osteoporos Rep       Date:  2016-12       Impact factor: 5.096

2.  Searching for additional endocrine functions of the skeleton: genetic approaches and implications for therapeutics.

Authors:  Jianwen Wei; Stephen Flaherty; Gerard Karsenty
Journal:  Expert Rev Endocrinol Metab       Date:  2015-06-16

Review 3.  Skeletal growth and bone mineral acquisition in type 1 diabetic children; abnormalities of the GH/IGF-1 axis.

Authors:  Manish Raisingani; Brar Preneet; Brenda Kohn; Shoshana Yakar
Journal:  Growth Horm IGF Res       Date:  2017-04-28       Impact factor: 2.372

Review 4.  Lifestyle Management of Diabetes: Implications for the Bone-Vascular Axis.

Authors:  Silvia Pieralice; Francesca Vigevano; Rossella Del Toro; Nicola Napoli; Ernesto Maddaloni
Journal:  Curr Diab Rep       Date:  2018-08-18       Impact factor: 4.810

5.  Association between osteocalcin and glucose metabolism: a meta-analysis.

Authors:  D-M Liu; X-Z Guo; H-J Tong; B Tao; L-H Sun; H-Y Zhao; G Ning; J-M Liu
Journal:  Osteoporos Int       Date:  2015-06-19       Impact factor: 4.507

6.  Estrogen Deficiency Exacerbates Type 1 Diabetes-Induced Bone TNF-α Expression and Osteoporosis in Female Mice.

Authors:  Sandi Raehtz; Hayley Bierhalter; Daniel Schoenherr; Narayanan Parameswaran; Laura R McCabe
Journal:  Endocrinology       Date:  2017-07-01       Impact factor: 4.736

7.  Bone health in subjects with type 1 diabetes for more than 50 years.

Authors:  Ernesto Maddaloni; Stephanie D'Eon; Stephanie Hastings; Liane J Tinsley; Nicola Napoli; Mogher Khamaisi; Mary L Bouxsein; Savitri M R Fouda; Hillary A Keenan
Journal:  Acta Diabetol       Date:  2017-02-25       Impact factor: 4.280

8.  Effects of GLP-1 receptor analogue liraglutide and DPP-4 inhibitor vildagliptin on the bone metabolism in ApoE-/- mice.

Authors:  Lizhi Zhang; Peicheng Li; Zhaosheng Tang; Qin Dou; Bo Feng
Journal:  Ann Transl Med       Date:  2019-08

Review 9.  The alliance of mesenchymal stem cells, bone, and diabetes.

Authors:  Nicola Napoli; Rocky Strollo; Angela Paladini; Silvia I Briganti; Paolo Pozzilli; Sol Epstein
Journal:  Int J Endocrinol       Date:  2014-07-16       Impact factor: 3.257

10.  Insulin and osteocalcin: further evidence for a mutual cross-talk.

Authors:  Francesco L Bilotta; Biagio Arcidiacono; Sebastiano Messineo; Marta Greco; Eusebio Chiefari; Domenico Britti; Tomoko Nakanishi; Daniela P Foti; Antonio Brunetti
Journal:  Endocrine       Date:  2017-09-02       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.